Sun Life Reports First Quarter 2022 Results
|
- Q1'22 reported net income of
$858 million decreased 8% and underlying net income(1) of$843 million decreased 1% from Q1'21. - Q1'22 reported EPS(2) was
$1.46 and underlying EPS(1)(2) was$1.44 .
"Sun Life delivered solid first quarter results driven by the strength of our diversified business model. We continue to deliver on our Purpose for Clients amidst a challenging economic environment and ongoing COVID-19 impacts. We saw our insurance and wealth sales grow this quarter, highlighting the value our Clients place on financial security and healthier lives, and we delivered strong long-term investment performance," said
Sun Life also announced the expansion of its strategic partnership with CIMB Niaga, a leading regional bank in
Quarterly results |
|||
Profitability |
Q1'22 |
Q1'21 |
|
Reported net income - Common shareholders ($ millions) |
858 |
937 |
|
Underlying net income ($ millions)(1) |
843 |
850 |
|
Reported EPS ($)(2) |
1.46 |
1.59 |
|
Underlying EPS ($)(1)(2) |
1.44 |
1.45 |
|
Reported return on equity ("ROE")(1) |
14.3% |
16.9% |
|
Underlying ROE(1) |
14.0% |
15.3% |
|
Growth |
Q1'22 |
Q1'21 |
|
Insurance sales ($ millions)(1) |
799 |
730 |
|
Wealth sales and asset management gross flows ($ millions)(1) |
57,887 |
65,962 |
|
Value of new business ("VNB") ($ millions)(1) |
258 |
278 |
|
Assets under management ("AUM") ($ billions)(1)(3) |
1,352 |
1,304 |
|
Financial Strength |
Q1'22 |
Q1'21 |
|
LICAT ratios (at period end)(4) |
|||
|
143% |
141% |
|
Sun Life Assurance(5) |
123% |
124% |
|
Financial leverage ratio (at period end)(1)(6) |
25.9% |
22.7% |
_________________ |
|
(1) |
Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in our MD&A for the period |
(2) |
All earnings per share ("EPS") measures refer to fully diluted EPS, unless otherwise stated. |
(3) |
AUM is comprised of General Funds and Segregated Funds on our Statements of Financial Position, and other third-party assets managed by the Company |
(4) |
For further information on the Life Insurance Capital Adequacy Test ("LICAT"), see section E - Financial Strength in this document. Our LICAT ratios are |
(5) |
|
(6) |
Includes |
Financial and Operational Highlights - Quarterly Comparison (Q1 2022 vs. Q1 2021)
Our strategy is focused on key business segments, where we aim to be a leader in the markets in which we operate.
($ millions, unless otherwise noted) |
||||||||||||
Reported net income (loss) - |
Underlying net income (loss)(1) |
Insurance sales(1) |
Wealth sales and asset |
|||||||||
Q1'22 |
Q1'21 |
change |
Q1'22 |
Q1'21 |
change |
Q1'22 |
Q1'21 |
change |
Q1'22 |
Q1'21 |
change |
|
|
263 |
405 |
(35)% |
298 |
285 |
5% |
332 |
233 |
42% |
4,939 |
4,435 |
11% |
|
169 |
211 |
(20)% |
118 |
171 |
(31)% |
148 |
154 |
(4)% |
— |
— |
— |
Asset Management |
308 |
230 |
34% |
326 |
291 |
12% |
— |
— |
— |
49,427 |
58,231 |
(15)% |
|
161 |
198 |
(19)% |
152 |
159 |
(4)% |
319 |
343 |
(7)% |
3,521 |
3,296 |
7% |
Corporate |
(43) |
(107) |
nm(2) |
(51) |
(56) |
nm(2) |
— |
— |
— |
— |
— |
— |
Total |
858 |
937 |
(8)% |
843 |
850 |
(1)% |
799 |
730 |
9% |
57,887 |
65,962 |
(12)% |
(1) |
Represents a non-IFRS financial measure. See the Non-IFRS Financial Measures section in this document and in the Q1 2022 MD&A. |
(2) |
Not meaningful. |
Reported net income of
Experience in the quarter consisted of higher investment gains, partially offset by morbidity reflecting longer durations for disability claims, and unfavourable credit impacts.
Aligned with our Purpose to help Clients achieve lifetime financial security, we launched Prospr by Sun Life, a hybrid advice solution combining a best-in-class digital platform with a team of licensed advisors, to meet Canadians' personalized and holistic financial planning needs. Prospr by Sun Life makes it easier for Canadians to select, prioritize and track their goals all in one place.
In the first quarter, COVID-19 impacts of
During Q1, we launched Benefits Explorer, an interactive platform designed to provide employees with personalized, live educational content and customized tools to help them make well-informed benefits decisions. We also continued to invest in our dental business and digital capabilities by partnering with Teledentistry.com. The service offers members 24/7 virtual access to dental providers, making it easier to get dental care and advice in emergencies while traveling or during evenings and weekends. This complements the recent announcement of our intention to acquire
_________ |
|
(1) |
|
(2) |
Refer to section C - Profitability in the Q1 2022 MD&A for more information about experience-related items and the Non-IFRS Financial Measures section in this document for a reconciliation between reported net income and underlying net income. |
(3) |
Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the Q1 2022 MD&A. |
Asset Management: A global leader in both public and alternative asset classes through MFS and SLC Management
Asset Management reported net income of $308 million increased
Asset Management ended Q1'22 with
The MFS pre-tax net operating profit margin(1) was 39% for Q1'22, consistent with prior year. The SLC Management fee-related earnings margin(1)(2) was 23%, down from 26%.
Through its collective expertise, long-term investing philosophy and active risk management, MFS continues to deliver on its consistent track record as a top-performing active asset manager. For 2021, MFS ranked in the top 10(3) for its 5- and 10-year performance across its
During Q1,
Experience in the quarter included higher investment gains, partially offset by higher mortality mainly in International, related to a small number of large claims. Foreign exchange translation led to a
We continue to expand our distribution channels across
Corporate reported net loss of
________ |
|
(1) |
Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the Q1 2022 MD&A. |
(2) |
Based on a trailing 12-month basis. |
(3) |
Barron's 2021 Fund Family rankings. |
(4) |
|
(5) |
Based on total assets, as at |
Earnings Conference Call
The Company's Q1'22 financial results will be reviewed at a conference call on
Media Relations Contact: |
Investor Relations Contact: |
|
|
Director, Corporate Communications |
Vice-President, Head of Investor Relations and Capital Markets |
Tel: 226-751-2391 |
Tel: 416-979-6496 |
Non-IFRS Financial Measures |
||
We report certain financial information using non-IFRS financial measures, as we believe that these measures provide information that is useful to investors in understanding our performance and facilitate a comparison of our quarterly and full year results from period to period. These non-IFRS financial measures do not have any standardized meaning and may not be comparable with similar measures used by other companies. For certain non-IFRS financial measures, there are no directly comparable amounts under IFRS. These non-IFRS financial measures should not be viewed in isolation from or as alternatives to measures of financial performance determined in accordance with IFRS. Additional information concerning non-IFRS financial measures and, if applicable, reconciliations to the closest IFRS measures are available in Q1 2022 MD&A under the heading M - Non-IFRS Financial Measures, in our annual MD&A under the heading L - Non-IFRS Financial Measures and the Supplementary Financial Information packages that are available on www.sunlife.com under Investors – Financial results and reports. |
||
1. Underlying Net Income and Underlying EPS |
||
Underlying net income (loss) and financial measures based on underlying net income (loss), including underlying EPS or underlying loss per share, and underlying ROE, are non-IFRS financial measures. Underlying net income (loss) removes from reported net income (loss) the impacts of the following items in our results under IFRS and when removed assist in explaining our results from period to period: |
||
(a) |
market-related impacts that differ from our best estimate assumptions, which include: (i) impacts of returns in equity markets, net of hedging, for which our best estimate assumptions are approximately 2% per quarter. This also includes the impact of the basis risk inherent in our hedging program, which is the difference between the return on underlying funds of products that provide benefit guarantees and the return on the derivative assets used to hedge those benefit guarantees; (ii) the impacts of changes in interest rates in the reporting period and on the value of derivative instruments used in our hedging programs including changes in credit and swap spreads, and any changes to the assumed fixed income reinvestment rates in determining the actuarial liabilities; and (iii) the impacts of changes in the fair value of investment properties in the reporting period; |
|
(b) |
assumption changes and management actions, which include: (i) the impacts of revisions to the methods and assumptions used in determining our liabilities for insurance contracts and investment contracts; and (ii) the impacts on insurance contracts and investment contracts of actions taken by management in the current reporting period, referred to as management actions which include, for example, changes in the prices of in-force products, new or revised reinsurance on in-force business, and material changes to investment policies for assets supporting our liabilities; and |
|
(c) |
other adjustments: |
|
(i) |
fair value adjustments on MFS' share-based payment awards that are settled with MFS' own shares and accounted for as liabilities and measured at fair value each reporting period until they are vested, exercised and repurchased - this adjustment enhances the comparability of MFS' results with publicly traded asset managers in |
|
(ii) |
acquisition, integration and restructuring costs - this adjustment enhances comparability of our results from period to period, by removing the impacts of costs, including the unwinding of the discount for certain liabilities related to acquisitions, that are not ongoing in nature and are incurred with the intent to generate benefits in future periods; |
|
(iii) |
certain hedges in |
|
(iv) |
other items that are unusual or exceptional in nature. |
|
All factors discussed in this document that impact our underlying net income are also applicable to reported net income. All EPS measures in this document refer to fully diluted EPS, unless otherwise stated. As noted below, underlying EPS excludes the dilutive impacts of convertible instruments. |
The following table sets out the post-tax amounts that were excluded from our underlying net income (loss) and underlying EPS and provides a reconciliation to our reported net income (loss) and EPS based on IFRS. |
||
Reconciliations of Select Net Income Measures |
Quarterly results |
|
($ millions, unless otherwise noted) |
Q1'22 |
Q1'21 |
Reported net income - Common shareholders |
858 |
937 |
Market-related impacts |
||
Equity market impacts |
||
Impacts from equity market changes |
(24) |
67 |
Basis risk impacts |
22 |
5 |
Equity market impacts |
(2) |
72 |
Interest rate impacts(1) |
||
Impacts of interest rate changes |
(57) |
161 |
Impacts of credit spread movements |
40 |
(8) |
Impacts of swap spread movements |
(13) |
(12) |
Interest rate impacts |
(30) |
141 |
Impacts of changes in the fair value of investment properties |
70 |
(4) |
Less: Market-related impacts |
38 |
209 |
Less: Assumption changes and management actions |
1 |
(4) |
Other adjustments |
||
Fair value adjustments on MFS' share-based payment awards |
(3) |
(44) |
Acquisition, integration and restructuring(2)(3) |
(21) |
(74) |
Less: Total of other adjustments |
(24) |
(118) |
Underlying net income |
843 |
850 |
Reported EPS (diluted) ($) |
1.46 |
1.59 |
Less: Market-related impacts ($) |
0.06 |
0.37 |
Assumption changes and management actions ($) |
— |
(0.01) |
Fair value adjustments on MFS' share-based payment awards ($) |
— |
(0.08) |
Acquisition, integration and restructuring ($) |
(0.04) |
(0.13) |
Impact of convertible securities on diluted EPS ($) |
— |
(0.01) |
Underlying EPS (diluted) ($) |
1.44 |
1.45 |
(1) Our exposure to interest rates varies by product type, line of business, and geography. Given the long-term nature of our business, we have a higher degree of sensitivity in respect of interest rates at long durations. |
||
(2) Amounts relate to acquisition costs for our SLC affiliates, BentallGreenOak, |
||
(3) The restructuring charge of $57 million in Q1'21 related to our strategy for our workspace and redefining the role of the office. |
The following table shows the pre-tax amount of underlying net income adjustments: |
||
Quarterly results |
||
($ millions, unless otherwise noted) |
Q1'22 |
Q1'21 |
Reported net income - Common shareholders (after-tax) |
858 |
937 |
Underlying net income adjustments (pre-tax): |
||
Less: Market-related impacts |
193 |
380 |
Assumption changes and management actions |
1 |
(6) |
Other adjustments(1) |
(26) |
(144) |
Total underlying net income adjustments (pre-tax) |
168 |
230 |
Less: Taxes related to underlying net income adjustments(1) |
(153) |
(143) |
Underlying net income (after-tax) |
843 |
850 |
(1) Effective |
Taxes related to underlying net income adjustments may vary from the expected effective tax rate range reflecting the mix of business based on the Company's international |
|||
2. Additional Non-IFRS Financial Measures Management also uses the following non-IFRS financial measures: |
|||
Assets under management. AUM is a non-IFRS financial measure that indicates the size of our company's asset management, wealth, and insurance assets. There is no |
|||
Other AUM is composed of retail, institutional and other-third party assets, as well as general fund and segregated fund assets managed by our joint ventures. In |
|||
Effective |
|||
Quarterly results |
|||
($ millions) |
Q1'22 |
Q1'21 |
|
General fund assets |
196,685 |
190,072 |
|
Segregated funds |
133,496 |
127,341 |
|
Other AUM |
1,021,972 |
986,833 |
|
Total assets under management |
1,352,153 |
1,304,246 |
|
Assumption changes and management actions. In this document the impacts of ACMA on shareholders' net income (after-tax) is included in reported net income and is excluded |
|||
Note 5.A of the Interim Consolidated Financial Statements for the period ended March 31, 2022 shows the pre-tax impacts of method and assumption changes on shareholders' and |
|||
The following table provides a reconciliation of the differences between the two measures. |
|||
Quarterly results |
|||
($ millions) |
Q1'22 |
Q1'21 |
|
Impacts of method and assumption changes on insurance contract liabilities (pre-tax) |
5 |
(8) |
|
Less: Participating policyholders(1) |
4 |
(4) |
|
Impacts of method and assumption changes excluding participating policyholders (pre-tax) |
1 |
(4) |
|
Less: Tax |
— |
(2) |
|
Impacts of method and assumption changes excluding participating policyholders (after-tax) |
1 |
(2) |
|
Add: Management actions (after-tax)(2) |
— |
(2) |
|
Other (after-tax)(3) |
— |
— |
|
Assumption changes and management actions (after-tax)(4)(5) |
1 |
(4) |
|
(1) Adjustment to remove the pre-tax impacts of method and assumption changes on amounts attributed to participating policyholders. |
|||
(2) Adjustment to include the after-tax impacts of management actions on insurance contract liabilities and investment contract liabilities which include, for example, changes in the prices |
|||
(3) Adjustments to include the after-tax impacts of method and assumption changes on investment contracts and other policy liabilities, and the pre-tax impact to Method and assumption |
|||
(4) Includes the tax impacts of ACMA on insurance contract liabilities and investment contract liabilities, reflecting the tax rates in the jurisdictions in which we do business. |
|||
(5) ACMA is included in reported net income and is excluded in calculating underlying net income, as described in section C - Profitability in the Q1 2022 MD&A. |
|||
Cash and other liquid assets. This measure is comprised of cash, cash equivalents, short-term investments, and publicly traded securities that are held at |
|||
($ millions) |
As at |
As at |
|
Cash, cash equivalents & short-term securities |
2,310 |
2,383 |
|
Debt securities(1) |
1,576 |
1,421 |
|
Equity securities(2) |
834 |
861 |
|
Cash and other liquid assets (held at |
4,720 |
4,665 |
|
(1) Includes publicly traded bonds. |
|||
(2) Includes ETF Investments. |
|||
(3) Includes |
3. Reconciliations of Select Non-IFRS Financial Measures |
||||||
Reported Net Income to Underlying Net Income Reconciliation - Pre-tax by |
||||||
Q1'22 |
||||||
($ millions) |
Canada |
U.S. |
Asset |
|
Corporate |
Total |
Reported net income (loss) - Common shareholders |
263 |
169 |
308 |
161 |
(43) |
858 |
Less: Market-related impacts (pre-tax)(1) |
123 |
60 |
— |
9 |
1 |
193 |
ACMA (pre-tax) |
(11) |
11 |
— |
1 |
— |
1 |
Other adjustments (pre-tax)(1)(2) |
— |
(6) |
(19) |
(1) |
— |
(26) |
Tax expense (benefit) on above items(2) |
(147) |
(14) |
1 |
— |
7 |
(153) |
Underlying net income (loss)(1) |
298 |
118 |
326 |
152 |
(51) |
843 |
Q1'21 |
||||||
Reported net income (loss) - Common shareholders |
405 |
211 |
230 |
198 |
(107) |
937 |
Less: Market-related impacts (pre-tax)(1) |
288 |
55 |
— |
36 |
1 |
380 |
ACMA (pre-tax) |
(6) |
(5) |
— |
3 |
2 |
(6) |
Other adjustments (pre-tax)(1)(2) |
— |
— |
(66) |
— |
(78) |
(144) |
Tax expense (benefit) on above items(2) |
(162) |
(10) |
5 |
— |
24 |
(143) |
Underlying net income (loss)(1) |
285 |
171 |
291 |
159 |
(56) |
850 |
(1) For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
||||||
(2) Effective |
From time to time, the Company makes written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements contained in this document include statements (i) relating to our strategies; (ii) relating to the expansion of our bancassurance partnership with CIMB Niaga; (iii) relating to our intention to acquire DentaQuest; (iv) relating to our growth initiatives and other business objectives; (v) relating to the plans we have implemented in response to the COVID-19 pandemic and related economic conditions and their impact on the Company, (vi) that are predictive in nature or that depend upon or refer to future events or conditions, and (vii) that include words such as "achieve", "aim", "ambition", "anticipate", "aspiration", "assumption", "believe", "could", "estimate", "expect", "goal", "initiatives", "intend", "may", "objective", "outlook", "plan", "project", "seek", "should", "strategy", "strive", "target", "will", and similar expressions. Forward-looking statements include the information concerning our possible or assumed future results of operations. These statements represent our current expectations, estimates, and projections regarding future events and are not historical facts, and remain subject to change, particularly in light of the ongoing and developing COVID-19 pandemic and its impact on the global economy and its uncertain impact on our business.
Forward-looking statements are not a guarantee of future performance and involve risks and uncertainties that are difficult to predict. Future results and shareholder value may differ materially from those expressed in these forward-looking statements due to, among other factors, the impact of the COVID-19 pandemic and related economic conditions on our operations, liquidity, financial conditions or results and the matters set out in Q1 2022 MD&A under the headings C - Profitability - 5 - Income taxes, E - Financial Strength and H - Risk Management and in
Important risk factors that could cause our assumptions and estimates, and expectations and projections to be inaccurate and our actual results or events to differ materially from those expressed in or implied by the forward-looking statements contained in this document, are set out below. The realization of our forward-looking statements, essentially depends on our business performance which, in turn, is subject to many risks, which have been further heightened with the current COVID-19 pandemic given the uncertainty of its duration and impact. Factors that could cause actual results to differ materially from expectations include, but are not limited to: market risks - related to the performance of equity markets; changes or volatility in interest rates or credit spreads or swap spreads; real estate investments; and fluctuations in foreign currency exchange rates; insurance risks - related to policyholder behaviour; mortality experience, morbidity experience and longevity; product design and pricing; the impact of higher-than-expected future expenses; and the availability, cost and effectiveness of reinsurance; credit risks - related to issuers of securities held in our investment portfolio, debtors, structured securities, reinsurers, counterparties, other financial institutions and other entities; business and strategic risks - related to global economic and political conditions; the design and implementation of business strategies; changes in distribution channels or Client behaviour including risks relating to market conduct by intermediaries and agents; the impact of competition; the performance of our investments and investment portfolios managed for Clients such as segregated and mutual funds; changes in the legal or regulatory environment, including capital requirements and tax laws; the environment, environmental laws and regulations; operational risks - related to breaches or failure of information system security and privacy, including cyber-attacks; our ability to attract and retain employees; legal, regulatory compliance and market conduct, including the impact of regulatory inquiries and investigations; the execution and integration of mergers, acquisitions, strategic investments and divestitures; our information technology infrastructure; a failure of information systems and Internet-enabled technology; dependence on third-party relationships, including outsourcing arrangements; business continuity; model errors; information management; liquidity risks - the possibility that we will not be able to fund all cash outflow commitments as they fall due; and other risks - COVID-19 matters, including the severity, duration and spread of COVID-19; its impact on the global economy, and its impact on Sun Life's business, financial condition and or results; risks associated with IFRS 17 Insurance Contracts and IFRS 9 Financial Instruments; our international operations, including our joint ventures; market conditions that affect our capital position or ability to raise capital; downgrades in financial strength or credit ratings; and tax matters, including estimates and judgements used in calculating taxes.
The following risk factors are related to our intention to purchase DentaQuest that could have a material adverse effect on our forward-looking statements: (1) the ability of the parties to complete the transaction; (2) failure of the parties to obtain necessary consents and approvals or to otherwise satisfy the conditions to the completion of the transaction in a timely manner, or at all; (3) our ability to realize the financial and strategic benefits of the transaction; and (4) the impact of the announcement of the transaction and the dedication of our and DentaQuest's resources to completing the transaction. These risks all could have an impact on our business relationships (including with future and prospective employees, Clients, distributors and partners) and could have a material adverse effect on our current and future operations, financial conditions and prospects.
The Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including
View original content to download multimedia:https://www.prnewswire.com/news-releases/sun-life-reports-first-quarter-2022-results-301545481.html
SOURCE
METROPOLITAN LIFE INSURANCE CO – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations
Sun Life declares dividends on Common and Preferred Shares payable in Q2 2022
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News